Moreover, a relationship has been proposed for the PMCA2 and HER2 levels in breast cancers; PMCA2 expression is activated in breast cancers, wherein PMCA high tumor levels predict increased mortality [26]. Here, ERBB2 is linked to breast carcinoma.